skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

The role of transdermal estrogen sprays and estradiol topical emulsion in the management of menopause-associated vasomotor symptoms

Review

(2088) Views  (802) Full article downloads

Authors: Amy M Egras, Elena M Umland

Published Date May 2010 Volume 2010:3 Pages 147 - 151
DOI: http://dx.doi.org/10.2147/IJGM.S4336

Amy M Egras, Elena M Umland

Jefferson School of Pharmacy, Thomas Jefferson University, Philadelphia, PA, USA

Abstract: Vasomotor symptoms (VMS) are among the most bothersome complaints of postmenopausal women. To date, the most widely studied and effective treatment for VMS is hormone replacement therapy, consisting of estrogen (in women without a uterus) or estrogen plus progestin (in women with a uterus). Traditionally, oral estrogens have been used for treatment. However, over the years, additional estrogen formulations have been developed including transdermal patches; vaginal rings, creams, and tablets; and injectable preparations. Two newer formulations are transdermal estrogen spray and estradiol topical emulsion. This review evaluates the current literature assessing the use of these two newer formulations for the treatment of VMS associated with menopause.

Keywords: menopause, vasomotor symptoms, transdermal estrogen spray, estradiol topical emulsion








Readers of this article also read:

Gamma knife radiosurgery for uveal melanoma ineligible for brachytherapy by the Collaborative Ocular Melanoma Study criteria
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Exercise prescription for Iranian midlife women
Erratum - Intracellular heavy metal nanoparticle storage
Efficacy of biorhythmic transdermal combined hormone treatment in relieving climacteric symptoms: a pilot study
Improvement of adenoviral vector-mediated gene transfer to airway epithelia by folate-modified anionic liposomes
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates
Incorporating bazedoxifene/conjugated estrogens into the current paradigm of menopausal therapy
  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University